Svmuu News: Cathie Wood stated that, according to research by ARK Invest, multiomics will be one of the most far-reaching applications of artificial intelligence and is expected to bring about structural changes in the healthcare sector. By combining multiomics technology with AI capabilities, it is possible to diagnose diseases at an early stage—before any physical symptoms appear—while significantly reducing the cost and time required for new drug R&D, accelerating the development and delivery of innovative therapies, and fundamentally improving the efficiency of the healthcare system.
Cathie Wood believes this trend will drive a shift in the healthcare model from traditional “sickcare” to true “healthcare,” marking a transition from reactive treatment to proactive prevention.